Daptomycin versus vancomycin in treatment of methicillin-resistant staphylococcus aureus meningitis in an experimental rabbit model

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1556-1558

  Bardak Ozcem, Selin ^a   Turhan, Tuncer ^a   Sipahi, Oguz Resat ^a   Arda, Bilgin ^a   Pullukcu, Husnu ^a   Yamazhan, Tansu ^a   Isikgoz Tasbakan, Meltem ^a   Sipahi, Hilal ^b   Ulusoy, Sercan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Bornova Public Health Center   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL MENINGITIS; BACTERIAL STRAIN; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DAPTOMYCIN; DISEASE MODELS, ANIMAL; MENINGITIS, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RABBITS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84874035808     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01996-12     Document Type: Article

References (10)

1. Bardak-Ozcem S, Sipahi OR. 2012. Approach to hospital-acquired and methicillin-resistant Staphylococcus aureus meningitis. Mediterr. J. Infect. Microb. Antimicrob. 1:13.
2. Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, Ulusoy S. 2005. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Int. J. Antimicrob. Agents 26:412- 415.
3. Bilgehan H. 2009. Klinik mikrobiyolojik tani, 3rd ed. Fakülteler Kitabevi, I? zmir, Turkey. (In Turkish.).
4. Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. 2006. Daptomycin is more efficacious than vancomycin against a methicillinsusceptible Staphylococcus aureus in experimental meningitis. J. Antimicrob. Chemother. 57:720 -723.
5. Stucki A, Cottagnoud M, Acosta F, Egerman U, Läuffer J, Cottagnoud P. 2012. Evaluation of ceftobiprole activity against a variety of Gramnegative pathogens, including Escherichia coli, Haemophilus influenzae (lactamase positive and lactamase negative), and Klebsiella pneumoniae, in a rabbit meningitis model. Antimicrob. Agents Chemother. 56:921- 925.
6. Mook-Kanamori BB, Rouse MS, Kang CI, van de Beek D, Steckelberg JM, Patel R. 2009. Daptomycin in experimental murine pneumococcal meningitis. BMC Infect. Dis. 9:50. doi:10.1186/1471-2334-9-50.
7. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. 2004. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39:1267-1284.
8. Tunkel AR, van de Beek D, Scheld WM. 2010. Acute meningitis, p 1189-1229. In Mandell GL, Bennett JE, Dolin R (ed), Principles and practice of infectious diseases, 7th ed, vol 1. Churchill Livingstone, Elsevier, New York, NY.
9. Sipahi OR, Bardak S, Turhan T, Arda B, Pullukcu H, Ruksen M, Aydemir S, Dalbasti T, Yurtseven T, Zileli M, Ulusoy S. 2011. Linezolid in the treatment of methicillin-resistant staphylococcal postneurosurgical meningitis: a series of 17 cases. Scand. J. Infect. Dis. 43:757- 764.
10. Cottagnoud P, Pfister M, Acosta F, Cottagnoud M, Flatz L, Kühn F, Müller HP, Stucki A. 2004. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob. Agents Chemother. 48:3928- 3933.